NCT02233972

A Drug-Drug Interaction Study To Investigate The Ginkgolides Meglumine Injection To Alter The Pharmacokinetics Of Midazolam

A Drug-Drug Interaction Study To Investigate The Ginkgolides Meglumine Injection To Alter The Pharmacokinetics Of Midazolam.

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 15 (actual)
• Sponsor: Jiangsu Kanion Pharmaceutical Co., Ltd · Industry
• Sex: Male
• Age: 18 Years – 40 Years
• Healthy volunteers: Accepted

Summary

This is an open label, randomized, Parallel Assignment, placebo-controlled study. One of the purposes of this study is to investigate the multiple dosing Ginkgolides Meglumine Injection to alter the pharmacokinetics of Midazolam, the other is to calculate the pharmacokinetic parameters after Single and multiple dosing of Ginkgolides Meglumine Injection.

Conditions

• Pharmacokinetics

Interventions

Type	Name	Description
DRUG	Midazolam
DRUG	Ginkgolides Meglumine Injection
DRUG	placebo

Timeline

• Start date: 2014-08-01
• Primary completion: 2014-10-01
• First posted: 2014-09-09
• Last updated: 2014-10-20

Locations

1 site across 1 country: China